Literature DB >> 16822639

Synthesis, regulation and production of urokinase using mammalian cell culture: a comprehensive review.

Pradip K Roychoudhury1, Shilpa S Khaparde, Bo Mattiasson, Ashok Kumar.   

Abstract

Urokinase, a serine protease, catalyzes the conversion of plasminogen to plasmin, which is responsible for dissolution of clots in blood vessels. It is an important drug for treatment of thromboembolic disease. Production of urokinase by mammalian cell culture has the following important steps: synthesis, regulation and secretion. Production and accumulation of this product in a bioreactor is a real challenge for biochemical engineers. Considerable information at molecular level needs to be understood for production of urokinase in order to correlate different parameters, which in turn can maximize the productivity. This information will be highlighted in this review. Moreover, urokinase production is a product-inhibited process. Therefore, in situ urokinase separation strategy is required to operate a bioreactor at its maximum urokinase formation rate. Integrated urokinase production and isolation processes developed recently will also be discussed briefly in this review.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822639     DOI: 10.1016/j.biotechadv.2006.05.002

Source DB:  PubMed          Journal:  Biotechnol Adv        ISSN: 0734-9750            Impact factor:   14.227


  6 in total

1.  The evolution of recombinant thrombolytics: Current status and future directions.

Authors:  Yogender Pal Khasa
Journal:  Bioengineered       Date:  2016-10-03       Impact factor: 3.269

2.  Disposable polymeric cryogel bioreactor matrix for therapeutic protein production.

Authors:  Era Jain; Ashok Kumar
Journal:  Nat Protoc       Date:  2013-04-04       Impact factor: 13.491

Review 3.  Gene expression in Mammalian cells and its applications.

Authors:  Kishwar Hayat Khan
Journal:  Adv Pharm Bull       Date:  2013-08-20

Review 4.  Can components of the plasminogen activation system predict the outcome of kidney transplants?

Authors:  Jerzy Jankun; Omar A Khan; Hesham I Mostafa; Puneet Sindhwani; Ewa Skrzypczak-Jankun
Journal:  Cent Eur J Immunol       Date:  2018-06-30       Impact factor: 2.085

Review 5.  Development and Testing of Thrombolytics in Stroke.

Authors:  Dmitri Nikitin; Seungbum Choi; Jan Mican; Martin Toul; Wi-Sun Ryu; Jiri Damborsky; Robert Mikulik; Dong-Eog Kim
Journal:  J Stroke       Date:  2021-01-31       Impact factor: 6.967

6.  Arrest Functions of the MIF Ligand/Receptor Axes in Atherogenesis.

Authors:  Sabine Tillmann; Jürgen Bernhagen; Heidi Noels
Journal:  Front Immunol       Date:  2013-05-16       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.